LAMEA Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Country and Growth Forecast, 2024

List of Tables

The Latin America, Middle East and Africa Peripheral Artery Disease Market would witness market growth of 9.3% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Peripheral Artery Disease Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $160 million by 2031. The Argentina market is showcasing a CAGR of 10.5% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 9% during (2024 - 2031).

Improved awareness campaigns and advances in diagnostic techniques enable earlier disease detection, significantly impacting patient outcomes and the approach to managing PAD. One of the primary factors contributing to the rise in public awareness of PAD is the collaborative endeavor of public health organizations, medical societies, and advocacy groups to inform healthcare professionals and the general public about the disease.

Advancements in diagnostic techniques have also significantly contributed to the earlier detection of PAD. Traditional diagnostic methods, such as the ankle-brachial index (ABI) test, continue to be valuable, but newer technologies enhance the accuracy and ease of diagnosis. Doppler ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA) are advanced imaging techniques that provide detailed visualizations of blood flow and arterial blockages. These tools enable healthcare providers to diagnose PAD more accurately and at an earlier stage, which is crucial for effective treatment planning.

There is an increasing demand for PAD treatment in South Africa, which is being driven by increased healthcare expenditure and improvements in healthcare infrastructure. The South African National Department of Health reports a substantial investment in healthcare services, focusing on non-communicable diseases like PAD. The prevalence of diabetes and hypertension, major risk factors for PAD, is notably high, affecting 11.3% and 44% of the adult population, respectively. Government initiatives aim to enhance early diagnosis and treatment of chronic diseases, supported by expanded healthcare facilities and improved access to medical care. Therefore, the region will present lucrative growth opportunities for market growth.

Based on Product Type, the market is segmented into Drugs (Antiplatelet Medicines, Statins, Anti Hypertensive Medication, and Others), and Devices (Peripheral Stents, Peripheral Angioplasty Balloons, Peripheral Catheters, Plaque Modification Devices, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, and Peripheral Accessories). Based on End User, the market is segmented into Hospitals, and Specialty Clinics.Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Becton, Dickinson and Company
Bayer AG
Koninklijke Philips N.V.
Abbott Laboratories
Terumo Corporation
B. Braun Melsungen AG
Medtronic PLC
Boston Scientific Corporation
Cardinal Health, Inc.
Biotronik SE & Co. KG

LAMEA Peripheral Artery Disease Market Report Segmentation

By Product Type

Drugs
- Antiplatelet Medicines
- Statins
- Anti Hypertensive Medication
- Others
Devices
- Peripheral Stents
- Peripheral Angioplasty Balloons
- Peripheral Catheters
- Plaque Modification Devices
- Inferior Vena Cava Filters
- Hemodynamic Flow Alteration Devices
- Peripheral Accessories

By End User

Hospitals
Specialty Clinics

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Peripheral Artery Disease Market, by Product Type
- 1.4.2 LAMEA Peripheral Artery Disease Market, by End User
- 1.4.3 LAMEA Peripheral Artery Disease Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Peripheral Artery Disease Market by Product Type

4.1 LAMEA Drugs Market by Country
4.2 LAMEA Peripheral Artery Disease Market by Drugs Type
- 4.2.1 LAMEA Antiplatelet Medicines Market by Country
- 4.2.2 LAMEA Statins Market by Country
- 4.2.3 LAMEA Anti Hypertensive Medication Market by Country
- 4.2.4 LAMEA Others Market by Country
4.3 LAMEA Devices Market by Country
4.4 LAMEA Peripheral Artery Disease Market by Devices Type
- 4.4.1 LAMEA Peripheral Stents Market by Country
- 4.4.2 LAMEA Peripheral Angioplasty Balloons Market by Country
- 4.4.3 LAMEA Peripheral Catheters Market by Country
- 4.4.4 LAMEA Plaque Modification Devices Market by Country
- 4.4.5 LAMEA Inferior Vena Cava Filters Market by Country
- 4.4.6 LAMEA Hemodynamic Flow Alteration Devices Market by Country
- 4.4.7 LAMEA Peripheral Accessories Market by Country

Chapter 5. LAMEA Peripheral Artery Disease Market by End User

5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Specialty Clinics Market by Country

Chapter 6. LAMEA Peripheral Artery Disease Market by Country

6.1 Brazil Peripheral Artery Disease Market
- 6.1.1 Brazil Peripheral Artery Disease Market by Product Type
  - 6.1.1.1 Brazil Peripheral Artery Disease Market by Drugs Type
  - 6.1.1.2 Brazil Peripheral Artery Disease Market by Devices Type
- 6.1.2 Brazil Peripheral Artery Disease Market by End User
6.2 Argentina Peripheral Artery Disease Market
- 6.2.1 Argentina Peripheral Artery Disease Market by Product Type
  - 6.2.1.1 Argentina Peripheral Artery Disease Market by Drugs Type
  - 6.2.1.2 Argentina Peripheral Artery Disease Market by Devices Type
- 6.2.2 Argentina Peripheral Artery Disease Market by End User
6.3 UAE Peripheral Artery Disease Market
- 6.3.1 UAE Peripheral Artery Disease Market by Product Type
  - 6.3.1.1 UAE Peripheral Artery Disease Market by Drugs Type
  - 6.3.1.2 UAE Peripheral Artery Disease Market by Devices Type
- 6.3.2 UAE Peripheral Artery Disease Market by End User
6.4 Saudi Arabia Peripheral Artery Disease Market
- 6.4.1 Saudi Arabia Peripheral Artery Disease Market by Product Type
  - 6.4.1.1 Saudi Arabia Peripheral Artery Disease Market by Drugs Type
  - 6.4.1.2 Saudi Arabia Peripheral Artery Disease Market by Devices Type
- 6.4.2 Saudi Arabia Peripheral Artery Disease Market by End User
6.5 South Africa Peripheral Artery Disease Market
- 6.5.1 South Africa Peripheral Artery Disease Market by Product Type
  - 6.5.1.1 South Africa Peripheral Artery Disease Market by Drugs Type
  - 6.5.1.2 South Africa Peripheral Artery Disease Market by Devices Type
- 6.5.2 South Africa Peripheral Artery Disease Market by End User
6.6 Nigeria Peripheral Artery Disease Market
- 6.6.1 Nigeria Peripheral Artery Disease Market by Product Type
  - 6.6.1.1 Nigeria Peripheral Artery Disease Market by Drugs Type
  - 6.6.1.2 Nigeria Peripheral Artery Disease Market by Devices Type
- 6.6.2 Nigeria Peripheral Artery Disease Market by End User
6.7 Rest of LAMEA Peripheral Artery Disease Market
- 6.7.1 Rest of LAMEA Peripheral Artery Disease Market by Product Type
  - 6.7.1.1 Rest of LAMEA Peripheral Artery Disease Market by Drugs Type
  - 6.7.1.2 Rest of LAMEA Peripheral Artery Disease Market by Devices Type
- 6.7.2 Rest of LAMEA Peripheral Artery Disease Market by End User

Chapter 7. Company Profiles

7.1 Becton, Dickinson, and Company
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
7.2 Bayer AG
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 SWOT Analysis
7.3 Koninklijke Philips N.V.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
  - 7.3.5.1 Acquisition and Mergers:
- 7.3.6 SWOT Analysis
7.4 Abbott Laboratories
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.4.5 Recent strategies and developments:
  - 7.4.5.1 Acquisition and Mergers:
- 7.4.6 SWOT Analysis
7.5 Terumo Corporation
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expenses
- 7.5.5 Recent strategies and developments:
  - 7.5.5.1 Product Launches and Product Expansions:
- 7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 SWOT Analysis
7.7 Medtronic PLC
- 7.7.1 Company overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.7.5 Recent strategies and developments:
  - 7.7.5.1 Acquisition and Mergers:
- 7.7.6 SWOT Analysis
7.8 Boston Scientific Corporation
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
  - 7.8.5.1 Acquisition and Mergers:
- 7.8.6 SWOT Analysis
7.9 Cardinal Health, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 SWOT Analysis
7.10. Biotronik SE & Co. KG
- 7.10.1 Company Overview
- 7.10.2 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 4 LAMEA Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 5 LAMEA Drugs Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Drugs Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 8 LAMEA Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 9 LAMEA Antiplatelet Medicines Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Antiplatelet Medicines Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Statins Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Statins Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA Anti Hypertensive Medication Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Anti Hypertensive Medication Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Devices Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Devices Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 20 LAMEA Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 21 LAMEA Peripheral Stents Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA Peripheral Stents Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA Peripheral Angioplasty Balloons Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA Peripheral Angioplasty Balloons Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Peripheral Catheters Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Peripheral Catheters Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Plaque Modification Devices Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Plaque Modification Devices Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Inferior Vena Cava Filters Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Inferior Vena Cava Filters Market by Country, 2024 - 2031, USD Million
TABLE 31 LAMEA Hemodynamic Flow Alteration Devices Market by Country, 2020 - 2023, USD Million
TABLE 32 LAMEA Hemodynamic Flow Alteration Devices Market by Country, 2024 - 2031, USD Million
TABLE 33 LAMEA Peripheral Accessories Market by Country, 2020 - 2023, USD Million
TABLE 34 LAMEA Peripheral Accessories Market by Country, 2024 - 2031, USD Million
TABLE 35 LAMEA Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 36 LAMEA Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 37 LAMEA Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 38 LAMEA Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 39 LAMEA Specialty Clinics Market by Country, 2020 - 2023, USD Million
TABLE 40 LAMEA Specialty Clinics Market by Country, 2024 - 2031, USD Million
TABLE 41 LAMEA Peripheral Artery Disease Market by Country, 2020 - 2023, USD Million
TABLE 42 LAMEA Peripheral Artery Disease Market by Country, 2024 - 2031, USD Million
TABLE 43 Brazil Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 44 Brazil Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 45 Brazil Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 46 Brazil Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 47 Brazil Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 48 Brazil Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 49 Brazil Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 50 Brazil Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 51 Brazil Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 52 Brazil Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 53 Argentina Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 54 Argentina Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 55 Argentina Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 56 Argentina Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 57 Argentina Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 58 Argentina Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 59 Argentina Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 60 Argentina Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 61 Argentina Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 62 Argentina Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 63 UAE Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 64 UAE Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 65 UAE Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 66 UAE Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 67 UAE Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 68 UAE Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 69 UAE Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 70 UAE Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 71 UAE Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 72 UAE Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 73 Saudi Arabia Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 74 Saudi Arabia Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 75 Saudi Arabia Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 76 Saudi Arabia Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 77 Saudi Arabia Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 78 Saudi Arabia Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 79 Saudi Arabia Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 80 Saudi Arabia Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 81 Saudi Arabia Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 82 Saudi Arabia Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 83 South Africa Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 84 South Africa Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 85 South Africa Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 86 South Africa Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 87 South Africa Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 88 South Africa Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 89 South Africa Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 90 South Africa Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 91 South Africa Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 92 South Africa Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 93 Nigeria Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 94 Nigeria Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 95 Nigeria Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 96 Nigeria Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 97 Nigeria Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 98 Nigeria Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 99 Nigeria Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 100 Nigeria Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 101 Nigeria Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 102 Nigeria Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 103 Rest of LAMEA Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 104 Rest of LAMEA Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 105 Rest of LAMEA Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 106 Rest of LAMEA Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 107 Rest of LAMEA Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 108 Rest of LAMEA Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 109 Rest of LAMEA Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 110 Rest of LAMEA Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 111 Rest of LAMEA Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 112 Rest of LAMEA Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 113 Key Information - Becton, Dickinson and Company
TABLE 114 Key Information - Bayer AG
TABLE 115 Key Information - Koninklijke Philips N.V.
TABLE 116 Key Information - Abbott Laboratories
TABLE 117 Key Information - Terumo Corporation
TABLE 118 Key Information - B. Braun Melsungen AG
TABLE 119 Key Information - Medtronic PLC
TABLE 120 Key Information - Boston Scientific Corporation
TABLE 121 key information - Cardinal Health, Inc.
TABLE 122 Key Information - Biotronik SE & Co. KG

LAMEA Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents